ClinicalTrials.gg
Sign In

Musculoskeletal Diseases clinical trials

The registry lists 752 studies for Musculoskeletal Diseases across more than 10 countries. 164 are recruiting or about to start. 328 of them are mainly about Musculoskeletal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 186 narrower conditions too, such as Arthritis, Rheumatoid: 31,040 studies, 6,118 open.

ClinicalTrials.gov finds 28,608 studies for Musculoskeletal Diseases. How that becomes 750 here

This page counts the studies the registry files under Musculoskeletal Diseases, and those it files under no condition that list Musculoskeletal Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 28,608Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −26,836Filed under a narrower condition, counted on its own pageArthritis, Rheumatoid 3,262 · Osteoarthritis, Knee 3,160 · Osteoarthritis 1,739 · Osteoporosis 1,495 · Fibromyalgia 1,179 · Shoulder Pain 667 · 171 more
  3. −23List Musculoskeletal Diseases as a condition, but the registry did not file them under itMost often written as “Orthopedic Disorder of Spine” (10), “Chronic Musculoskeletal Disease” (8), and “Musculoskeletal Disease Other” (2). The registry filed 9 of them under no condition at all, and the others under other conditions only, most often Chronic Pain (5) and Nervous System Diseases (1).
  4. −999Match it another way4 name it in the title and 995 by a synonym or other text the search reads.
  5. 750The count on this page

Get an email when these change. Save the Musculoskeletal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
414
Recruiting
100
Status unknown
77
Not yet recruiting
48
Terminated
36
Active, not recruiting
36

Phase

Phase 2
73
Phase 3
61
Phase 1
36
Phase 4
14
Early Phase 1
4

Where

United States
227
Turkey
86
Canada
75
Spain
73
United Kingdom
69
Italy
62

Who runs them

National Research Centre for the Working Environment, Denmark (14) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio (13) · AbbVie (13) · Afyonkarahisar Health Sciences University (10) · Chinese University of Hong Kong (10) · QED Therapeutics, a BridgeBio company (8) · BioMarin Pharmaceutical (8) · Cairo University (8)

What is being tested here

Drugs under test in Musculoskeletal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Infigratinib325
Levobupivacaine203
Cholecalciferol113
Tranexamic Acid113
Testosterone 17 beta-cypionate111
Testosterone111
Finasteride111
Delpacibart zotadirsen111
Platelet rich plasma101
Hyaluronic Acid101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 3 open · Local anesthetics 2 open · Antifibrinolytics 1 open

Coming up

13phase 3 studies under way
51studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 100 Musculoskeletal Diseases studies recruiting now, 39 (39%) set no upper age limit and 44 (44%) stop at 75 or younger. 21 (21%) take children under 18. 0 (0%) are for women only and 1 (1%) for men only; 22 (22%) take healthy volunteers.

Recruiting studies that take each age, of 100
AgeWomenMen
1017 (17%)18 (18%)
1876 (76%)76 (76%)
3080 (80%)80 (80%)
4082 (82%)82 (82%)
5083 (83%)83 (83%)
6580 (80%)80 (80%)
7566 (66%)66 (66%)
8553 (53%)53 (53%)

Across all 752 studies, recruiting or not: 47% stop at 75 or younger and 35% at 65; 20% take children; 5% are for women only and 3% for men only; 26% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Musculoskeletal Diseases studies take

Of 30 phase 2 interventional studies under Musculoskeletal Diseases, half reached primary completion within 34 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 234 mo21–66 · 30 studies——
Phase 328 mo23–44 · 27 studies26 mo22–44 · 26 studies—
Interventional, no phase16 mo6–36 · 266 studies—16 mo6–38 · 251 studies
Observational27 mo7–74 · 107 studies—18 mo7–60 · 86 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Stopped1

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 752. Browse all 752 → or search them.